SIRT1: The first key to unlocking the mystery of cardiovascular diseases
Frontiers in Pharmacology · 06.01.2026 · 16
DOI: 10.3389/fphar.2025.1668718 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 06.01.2026. Verfasst von Khuzin Dinislam und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Department of Pharmacology, College of Pharmacy, and Department of Cardiology,…. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 313 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiovascular disease, (CVD) the leading cause of death worldwide, encompasses various heart and vascular disorders that significantly elevate morbidity and mortality rates. Sirtuin 1 (SIRT1), a NAD + dependent deacetylase, plays a key role in cardiovascular health and pathology by regulating fundamental processes such as endothelial function, oxidative stress, inflammation, senescence, metabolism, cardiac hypertrophy, and heart failure. Through these mechanisms, SIRT1 emerges as critical factor in the pathophysiology of CVDs, including heart failure, atherosclerosis, hypertension, and myocardial infarction. SIRT1 modulates several cellular pathways to regulate complex cellular processes associated with cardiovascular disorders. This review summarizes recent findings regarding the physiological and pathological roles of SIRT1 related to heart diseases and explores the therapeutic potential of targeting SIRT1 and sirtuin family members for CVD treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Department of Pharmacology, College of Pharmacy, and Department of Cardiology, the Second Affiliated Hospital, Harbin Medical Uni-versity, Harbin, C…
- State Key Laboratory-Province Key Laboratories of Biomedicine-Pharmaceutics of China, and Key Laboratory of Cardiovascular Research, Ministry of Education, College of Pharmacy, Harbin, China.
- Research Unit of Noninfectious Chronic Diseases in Frigid Zone (2019RU070), Chinese Academy of Medical Sciences, Harbin, China.
- Bashkir State Medical University, Ministry of Health of Russia, Ufa, Russia.
Zitieren
APA
Dinislam, K., Khoso, M. A., Kataev, V. A., Meshcheryakova, S., Liu, H., Liu, L., Guo, M., Wang, S., Lou, H., Zhang, Y., & Liu, X. (2026). SIRT1: The first key to unlocking the mystery of cardiovascular diseases. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1668718
Vancouver
Dinislam K, Khoso MA, Kataev VA, Meshcheryakova S, Liu H, Liu L, et al. SIRT1: The first key to unlocking the mystery of cardiovascular diseases. Frontiers in Pharmacology. 2026;16. doi:10.3389/fphar.2025.1668718
BibTeX
@article{Dinislam2026,
author = {Dinislam, Khuzin and Khoso, Muneer Ahmed and Kataev, Valeriy A and Meshcheryakova, Svetlana and Liu, Heng and Liu, Ling and Guo, Madi and Wang, Song and Lou, Han and Zhang, Yong and Liu, Xin},
title = {SIRT1: The first key to unlocking the mystery of cardiovascular diseases},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {16},
doi = {10.3389/fphar.2025.1668718}
}
EUVIMED